精鼎医药任命克莱尔·格雷斯为公司首席患者官,将助力推进以“患者为中心”的临床研究

2021-02-02 精鼎医药 精鼎医药

2021年1月4日,精鼎医药,一家领先的、致力于在临床开发到商业化的各个阶段加速创新疗法的研发和上市,以改善人类健康的解决方案提供者。

2021年1月4日,精鼎医药,一家领先的、致力于在临床开发到商业化的各个阶段加速创新疗法的研发和上市,以改善人类健康的解决方案提供者,近日宣布公司已任命克莱尔·格雷斯(Clare Grace)博士作为公司首任首席患者官。此次任命体现出患者在精鼎医药的药物开发战略中扮演核心的作用。
 
精鼎医药是第一家任命首席患者官的CRO龙头企业,充分彰显了精鼎医药对提升患者在临床研究中的影响力,以及推动基于患者个性化需求设计未来临床试验的承诺。
 
精鼎医药首席医学兼科学官Sy Pretorius博士表示:“我们所作的一切工作都是围绕患者展开的。克莱尔在实施围绕患者和研究中心的创新项目方面有着非常卓越的经历,因此我们认为她是带领精鼎医药团队实施以患者为中心的药物开发策略的不二人选。我们非常欢迎克莱尔加入精鼎医药,希望在她的领导下,公司能为全球的患者和研究中心提供更好的支持。”
 
格雷斯博士表示: “我很高兴能够加入精鼎医药,助力公司继续落实‘以患者为中心’的理念,从而提升临床试验的质量、加速将新疗法带给全球患者。 我期待与各临床研究中心和技术合作伙伴紧密合作以改善患者体验,基于患者视角优化临床研究的设计与运营,并进一步增强我们基于客户需求提供创新临床试验解决方案的能力。”
 
格雷斯博士在CRO和生物制药行业拥有20多年的工作经验。2018年,她被PharmaVoice评为“制药业百位最具感召力的领袖”之一。格雷斯博士持有英格兰曼彻斯特科技大学分子肿瘤学博士学位以及利物浦约翰·摩尔斯大学应用生物化学学士学位。 格雷斯博士积极参与多个全球和国家层面的顾问小组的工作,这其中包括临床研究中心协会(SCRS)以及SCRS领导委员会。
 
作为精鼎医药的首席患者官,格雷斯博士将负责领导与全球患者倡导组织​​和研究中心相关的工作,包括制定提升患者参与临床试验积极性的策略、提升临床试验多样性以及采用创新方法帮助团队和客户更有效地与研究中心开展工作。在加入精鼎医药之前,她曾任Syneos Health(此前为INC Research)公司副总裁,主管研究中心管理和患者可及性方面的工作, 包括统筹管理各部门参与的与患者互动、可行性研究、中心的选择及战略合作关系、研究者支付相关的工作。此外她还曾作为高管供职于PPD、阿斯利康和Antisoma等公司,负责患者和研究中心的管理。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1950414, encodeId=8351195041470, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76612, encryptionId=c53ce6612b8, topicName=精鼎医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Feb 01 02:20:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916275, encodeId=4a479162e5ef, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jan 13 16:37:13 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410101, encodeId=30d81410101ec, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jan 13 14:20:18 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915764, encodeId=b567915e6444, content=如<a href='/topic/show?id=b086512e33c' target=_blank style='color:#2F92EE;'>#心肌梗死#</a>、<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a>,, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51273, encryptionId=b086512e33c, topicName=心肌梗死), TopicDto(id=23982, encryptionId=ce9d239823b, topicName=二甲双胍)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/0a46e2191a5242699349a9874b62d33a/2efbcdab43d94c83b8335fe60762edd5.jpg, createdBy=20395444502, createdName=枢筋寰骨, createdTime=Tue Jan 12 06:58:17 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1950414, encodeId=8351195041470, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76612, encryptionId=c53ce6612b8, topicName=精鼎医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Feb 01 02:20:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916275, encodeId=4a479162e5ef, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jan 13 16:37:13 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410101, encodeId=30d81410101ec, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jan 13 14:20:18 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915764, encodeId=b567915e6444, content=如<a href='/topic/show?id=b086512e33c' target=_blank style='color:#2F92EE;'>#心肌梗死#</a>、<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a>,, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51273, encryptionId=b086512e33c, topicName=心肌梗死), TopicDto(id=23982, encryptionId=ce9d239823b, topicName=二甲双胍)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/0a46e2191a5242699349a9874b62d33a/2efbcdab43d94c83b8335fe60762edd5.jpg, createdBy=20395444502, createdName=枢筋寰骨, createdTime=Tue Jan 12 06:58:17 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-01-13 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1950414, encodeId=8351195041470, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76612, encryptionId=c53ce6612b8, topicName=精鼎医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Feb 01 02:20:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916275, encodeId=4a479162e5ef, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jan 13 16:37:13 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410101, encodeId=30d81410101ec, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jan 13 14:20:18 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915764, encodeId=b567915e6444, content=如<a href='/topic/show?id=b086512e33c' target=_blank style='color:#2F92EE;'>#心肌梗死#</a>、<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a>,, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51273, encryptionId=b086512e33c, topicName=心肌梗死), TopicDto(id=23982, encryptionId=ce9d239823b, topicName=二甲双胍)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/0a46e2191a5242699349a9874b62d33a/2efbcdab43d94c83b8335fe60762edd5.jpg, createdBy=20395444502, createdName=枢筋寰骨, createdTime=Tue Jan 12 06:58:17 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-01-13 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1950414, encodeId=8351195041470, content=<a href='/topic/show?id=c53ce6612b8' target=_blank style='color:#2F92EE;'>#精鼎医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76612, encryptionId=c53ce6612b8, topicName=精鼎医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Feb 01 02:20:18 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916275, encodeId=4a479162e5ef, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Wed Jan 13 16:37:13 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410101, encodeId=30d81410101ec, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Jan 13 14:20:18 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915764, encodeId=b567915e6444, content=如<a href='/topic/show?id=b086512e33c' target=_blank style='color:#2F92EE;'>#心肌梗死#</a>、<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a>,, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51273, encryptionId=b086512e33c, topicName=心肌梗死), TopicDto(id=23982, encryptionId=ce9d239823b, topicName=二甲双胍)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/0a46e2191a5242699349a9874b62d33a/2efbcdab43d94c83b8335fe60762edd5.jpg, createdBy=20395444502, createdName=枢筋寰骨, createdTime=Tue Jan 12 06:58:17 CST 2021, time=2021-01-12, status=1, ipAttribution=)]